GlassScriptPhysician profile
Deirdre R Washington
NPI 1164570032
$3,191.46
in general payments reported to CMS, 2019-2025
28 companies · $225 in 2025
The $225 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $908 · 2020: $322 · 2021: $136 · 2022: $481 · 2023: $548 · 2024: $572 · 2025: $225.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,344.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,344.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,004.34 | 2022-2025 | Intellis Adaptivestim, Accurian, Kyphon Express II Kyphopak Tray |
| Nevro Corp. | $825.77 | 2019-2023 | Senza |
| Astrazeneca Pharmaceuticals LP | $180.98 | 2019-2021 | |
| West Therapeutics Development, LLC | $165.77 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $145.09 | 2019-2024 | Relistor |
| Tesaro, INC. | $96.16 | 2019 | |
| Biodelivery Sciences International, INC. | $73.34 | 2019 | |
| Abbott Laboratories | $68.19 | 2025 | Eterna |
| Nalu Medical, INC. | $61.25 | 2024 | Nalu Neurostimulation System |
| Collegium Pharmaceutical, INC. | $57.92 | 2019 | |
| Seagen INC. | $52.11 | 2019-2022 | |
| Daiichi Sankyo INC. | $48.55 | 2019-2020 | |
| Globus Medical, INC. | $44.26 | 2025 | Senza |
| Eisai INC. | $39.72 | 2020-2021 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $39.63 | 2022-2023 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $34.58 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $31.23 | 2020-2022 | |
| Dendreon Pharmaceuticals LLC | $25.89 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $24.90 | 2019 | |
| Boston Scientific Corporation | $23.10 | 2023 | |
| Protega Pharmaceutials INC | $23.00 | 2025 | Roxybond |
| Scilex Pharmaceuticals INC. | $22.57 | 2025 | |
| Saluda Medical Americas, INC. | $22.22 | 2025 | Evoke |
| Genzyme Corporation | $17.19 | 2020 | |
| Exelixis INC. | $16.29 | 2019 | |
| Braeburn INC. | $15.89 | 2025 | Brixadi |
| Puma Biotechnology, INC. | $15.82 | 2019 | |
| Incyte Corporation | $15.70 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deirdre Washington listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.